Associations Among Obesity, Acute Weight Gain, and Response to Treatment with Olanzapine in Adolescent Schizophrenia
出版年份 2013 全文链接
标题
Associations Among Obesity, Acute Weight Gain, and Response to Treatment with Olanzapine in Adolescent Schizophrenia
作者
关键词
-
出版物
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Volume 23, Issue 8, Pages 522-530
出版商
Mary Ann Liebert Inc
发表日期
2013-10-11
DOI
10.1089/cap.2012.0099
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neural Correlates of Weight Gain With Olanzapine
- (2012) Jose Mathews et al. ARCHIVES OF GENERAL PSYCHIATRY
- Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
- (2012) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized, Double-Blind Study of Paliperidone Extended-Release in Treatment of Acute Schizophrenia in Adolescents
- (2011) Jaskaran Singh et al. BIOLOGICAL PSYCHIATRY
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Management of Schizophrenia in Children and Adolescents
- (2011) Gabriele Masi et al. DRUGS
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- The association between weight change and symptom reduction in the CATIE schizophrenia trial
- (2011) Eric Hermes et al. SCHIZOPHRENIA RESEARCH
- Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome
- (2010) David E Kemp et al. BIPOLAR DISORDERS
- Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
- (2010) Cynthia L. Ogden JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia
- (2009) Magali Haas et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Preliminary Findings Regarding Overweight and Obesity in Pediatric Bipolar Disorder
- (2009) Benjamin Goldstein et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder
- (2009) Ludmila A. Kryzhanovskaya et al. JOURNAL OF CLINICAL PSYCHIATRY
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia
- (2008) Robert L. Findling et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effectiveness of second generation antipsychotics: A systematic review of randomized trials
- (2008) Erik Johnsen et al. BMC Psychiatry
- Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Ludmila Kryzhanovskaya et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started